Narval
PrivateLast Round
Accelerator
May 29, 2024
Total Funding Raised
$4.02M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Narval is a biotechnology company that develops synthetic Antibody Mimetic Proteins™ designed to replace conventional monoclonal antibodies in therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Defense Tech
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Narval Comparables
Compare Narval with similar companies based on industry and business-model similarity.
Narval Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 29, 2024 | ||||
| Accelerator | Mar 11, 2024 |
Key People
Founding team and executive leadership
Narval Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Accelerator |
| Techstars | Accelerator |
| BioTools Innovator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 35% MoM, reaching 3.8K.
- Mar 11, 2024
$20K round led by Techstars
Narval Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Narval's valuation, stock price, and market status.
Is Narval a public or private company?
Narval is a private company.
What is the current stock price of Narval?
Narval is a private company with no public stock price. No recent secondary market data is available.
How much is Narval worth (valuation)?
Valuation information for Narval is not publicly available.
Can I buy Narval stock?
Narval shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Narval's last funding round?
Narval's most recent funding round was Accelerator on March 11, 2024.
Who are the main investors in Narval?
Key investors in Narval include Techstars, Strobe Ventures.
Will Narval IPO soon?
No public IPO plans have been announced for Narval.
How can I track Narval secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Narval's secondary market activity and sign up for updates.